Carrada-Bravo T

Language: Spanish
References: 24
Page: 67-72
PDF size: 74.49 Kb.

ABSTRACT

An 11 year-old boy was admitted to the hospital due to fever, headache, diffuse abdominal tenderness, malaise and convulsions. In the bone - marrow culture was identified Salmonella typhi; the biochemical tests and positive agglutination test allowed to characterize the O cell-wall lipopolysaccharide and the Vi capsular antigen. The radiological findings of thickening of the terminal ileum with enlarged mesenteric lymph nodes was consistent with the clinical diagnosis of typhoid fever. This report described the clinical rules for the diagnosis of this disease and their confirmation by means of the laboratory and other exams. Also it is mentioned the epidemiological study in order to know the possible infection source and the way of the transmission of the S. typhi: it was found that the healthy mother carried the microorganism. The boy was treated with oral chloramphenicol, but it is mentioned too other antibiotics.

REFERENCES

1. Kumate J, Gutiérrez G, Muños O, Santos PY. Manual de infectología clínica. 16a ed. México DF; Méndez Ed, 2001: 175-184.

2. Peredo-López-Valarde MA, González-Saldaña N, Hernández-Tepichín G. Fiebre tifoidea. En: González-Saldaña N, Torales-Torales N, Gómez-Barreto D, eds. Infectología clínica pediátrica. México DF: Trillas, 1994.

3. Parry ChM, Tinh-Hien T, Dougan G, White NJ, Farrat JJ. Typhoid Fever. N Engl J Med 2002; 347; 1770-82.

4. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986; 8: 329-49.

5. Carrada-Bravo T. La fiebre tifoidea y la vacunación antitifóidica. Salud Pública Méx 1981; 23: 103-58.

6. Carrada-Bravo T. Guía para diagnóstico y prevención de la fiebre tifoidea. Rev Méx Pediatr 1983; 50: 5-20.

7. Gamboa-Marrufo JD, Valencia- Mayoral P, Feria-Kaiser C, Velásquez-Jones L. Fiebre de origen oscuro, presentación de 180 casos pediátricos. Gac Med Méx 1992; 128: 379-86.

8. Farmer P, Brasgoz N, Murtagh MJ, Graeme-Cook FM. Case records of the Massachusetts General Hospital. N Engl J Med 1999; 340: 869-76.

9. Mendoza HP, Terminel VM, Ruiz ML. Experiencias bacteriológicas, clínicas y terapéuticas, en 1,676 casos de fiebre tifoidea. Gac Med Méx 1974; 108: 85-94.

10. Bopps CA, Breener FW, Wells JG. Escherichia, Shigella and Salmonella. In: Murray PR, Baron EJ, Pfaller MA. Manual of clinical Microbiology. 1999: 459-74.

11. Dusch H, Altewegg M. Evaluation of five new plating media for isolation of Salmonella species. J Clin Microbiol 1995; 33: 802-804.

12. Laboratorio Nacional de Salud Pública. Manual de técnicas y procedimientos. El análisis microbiológico del agua potable. México, D.F.: Secretaría de Salud, 1989.

13. Farner JJ, Nelly MT. Enterobacteriaceae. In: Ballow A, Hausler WJ, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology. Washington DC: American Society for Microbiology 1991: 183-360.

14. Bhutta ZA, Naqui SH, Razzaq RA. Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis 1991; 13: 832-6.

15. Gupta A. Multidrug–resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis J 1994; 13; 134-40.

16. Díaz-Godínez MC, Muñoz-Hernández O. Utilización del ensayo enzimático inmunoespecífico (ELISA) para diagnóstico de la fiebre tifoidea. Arch Invest Med (Méx) 1980; 11: 267-71.

17. Gotuzzo E, Carrillo C. Quinolones in typhoid fever. Infect Dis Clin Pract 1994; 3: 345-51.

18. Tran TH, Bethell DB, Nguyen TT. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20: 917-23.

19. Wallace MR, Yousif AA, Mahroos GA. Ciprofloxacin versus ceftriaxona in the treatment of multiresistant typhoid fever. Eur J Clin Microbiol Infect Dis 1993; 12: 907-610.

20. Budd W. Typhoid fever: its nature, mode of spreading, and prevention. London: Longmans–Green, 1873.

21. Satein MB, Wasserman SS, Tacket CO, Edelman R, Hone D, Lindberg AA and citorine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 1994; 170: 1508-17.

22. Black RE, Cisneros L, Levine MM, Banfi A, Lobos H, Rodríguez H. Case–control study to identify risk factors for pediatric endemic typhoid fever in Santiago, Chile. Bull World Health Organ 1985; 63; 899-904.

23. Invanoff B. Typhoid fever: global situation and WHO recommendations. Southeast Asia. J Trop Med Public Health 1995; 26(Suppl 2): 1-6.

24. Lin FYC, Ho VA, Khiem HB. The efficacy of a Salmonella typhi Vi- conjugate vaccine in two-to-five year-old children. N Engl J Med 2001; 344: 1263-9.